Noul Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
153
- Stock Symbol
-
376930
- Share Price
-
$1.45
- (As of Friday Closing)
Noul General Information
Description
Noul Co Ltd provides solutions for chronic and systemic problems in healthcare. The company's miLab is an all-in-one, fully-automated device which can process sample preparation and AI diagnostic in one workflow. It integrates technologies from computer vision AI, bio, hardware, and software engineering.
Contact Information
Website
www.noul.comCorporate Office
- B-6F/10F, 338, Gwanggyojungang-ro
- Suji-gu
- Yongin-si, Gyeonggi-do 16942
- South Korea
Corporate Office
- B-6F/10F, 338, Gwanggyojungang-ro
- Suji-gu
- Yongin-si, Gyeonggi-do 16942
- South Korea
Noul Stock Performance
As of 13-Nov-2026, Noul’s stock price is $1.45. Its current market cap is $16.4M with 11.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.45 | $1.60 | $0.82 - $10.44 | $16.4M | 11.4M | 683K | -$1.62 |
Noul Financials Summary
As of 30-Jun-2026, Noul has a trailing 12-month revenue of $2.52M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 16,473 | 58,541 | 62,840 | 101,977 |
| Revenue | 2,520 | 3,599 | 1,174 | 2,091 |
| EBITDA | (11,729) | (12,286) | (15,255) | (11,081) |
| Net Income | (13,551) | (14,022) | (16,468) | (12,483) |
| Total Assets | 16,812 | 27,239 | 25,668 | 43,127 |
| Total Debt | 2,504 | 4,945 | 7,953 | 6,053 |
Noul Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Noul Patents
Noul Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026049125-A1 | Method and device for acquiring red blood cell information using image of blood smear slide | Pending | 30-Aug-2024 | ||
| WO-2026049126-A1 | Method and device for determining region of interest of blood smear slide | Pending | 30-Aug-2024 | ||
| WO-2026042982-A1 | Method and device for classifying specimens included in images by using artificial intelligence | Pending | 20-Aug-2024 | ||
| WO-2024167058-A1 | Illuminating device for microscope | Inactive | 08-Feb-2023 | ||
| EP-4653840-A1 | Fixative composition for preparing smear specimens of biological samples | Pending | 16-Jan-2023 | G01N1/30 |
Noul Signals
Noul ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Software & Services
Industry
Rank
Percentile
Enterprise and Infrastructure Software
Subindustry
Rank
Percentile
Noul FAQs
-
When was Noul founded?
Noul was founded in 2015.
-
Where is Noul headquartered?
Noul is headquartered in Yongin-si, South Korea.
-
What is the size of Noul?
Noul has 153 total employees.
-
What industry is Noul in?
Noul’s primary industry is Diagnostic Equipment.
-
Is Noul a private or public company?
Noul is a Public company.
-
What is Noul’s stock symbol?
The ticker symbol for Noul is 376930.
-
What is the current stock price of Noul?
As of 13-Nov-2026 the stock price of Noul is $1.45.
-
What is the current market cap of Noul?
The current market capitalization of Noul is $16.4M.
-
What is Noul’s current revenue?
The trailing twelve month revenue for Noul is $2.52M.
-
What is Noul’s annual earnings per share (EPS)?
Noul’s EPS for 12 months was -$1.62.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process